Management of Breast Mass with Previous Benign Excision Biopsy
Breast conservation surgery is not necessary for a breast mass in the upper outer quadrant with a previous benign excision biopsy finding. 1
Assessment of the Current Situation
- For a patient with a history of excision biopsy showing benign findings, routine breast screening is the recommended approach rather than additional surgery 1
- When a previous excision biopsy has confirmed benign pathology that is concordant with imaging, the patient should return to routine screening protocols 1
- The upper outer quadrant location does not change management when previous pathology was benign 1
Follow-up Recommendations After Benign Biopsy
- Physical examination with or without ultrasound or mammogram is recommended every 6-12 months for 1-2 years to ensure stability of the biopsy site 1, 2
- After 1-2 years of stability, the patient can return to routine breast screening 3, 1
- This surveillance approach is necessary because patients with a history of benign breast disease have a slightly increased risk for subsequent biopsies or cancer development 2
When Additional Intervention Would Be Warranted
- If the previously biopsied area shows an increase in size during follow-up, repeat tissue sampling should be performed 1
- New suspicious features on imaging (BI-RADS 4 or 5) would warrant additional biopsy rather than immediate surgical excision 1
- If there is discordance between pathology and imaging findings from the previous biopsy, surgical excision would be indicated 1
Specific Scenarios Requiring Further Intervention
- Atypical findings on previous pathology (atypical hyperplasia, LCIS) would require consideration of risk reduction therapy rather than additional surgery 1
- Papillary lesions, radial scars, or potential phyllodes tumors on previous pathology may warrant surgical excision even with benign findings 1
- Patient anxiety or request is a valid indication for surgical excision even with benign findings 4
Alternative Approaches to Surgical Excision
- Ultrasound-guided vacuum-assisted excision can be considered as a minimally invasive alternative to surgical excision for removal of residual benign breast masses 5, 6
- This approach has shown complete removal rates of 92-93.5% with minimal complications and better cosmetic results than conventional surgery 6, 7
Common Pitfalls and Caveats
- Distinguishing between fibroadenoma and phyllodes tumor can be difficult on core biopsy, and surgical excision may be warranted for masses >2cm even with benign findings 4, 8
- Borderline lesions (such as benign phyllodes tumors) may be missed on core biopsy, with studies showing up to 6.8% of probably benign masses ≥2cm may be borderline lesions 8
- Growing masses on follow-up imaging have a higher likelihood of being non-benign (23.1% in one study), warranting closer evaluation 8